Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal JunctionJin Li, Hao Yu, Wei Liu et al.|Journal of Clinical Oncology|2016Cited by 1k
FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1Chunpeng Yu, Jun Liang|Molecular Medicine Reports|2017Cited by 30
[Expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2014 version)].Yan Sun, Ying Cheng, Zhongzhen Guan et al.|PubMed|2014Cited by 21